In this article, we will explore the signs and symptoms of hereditary angioedema (HAE) and its underlying causes. We will also look at available treatment options, including the medication Takhzyro which is used to prevent HAE attacks.
Signs and Symptoms of Hereditary Angioedema
Swelling: One of the hallmark symptoms of HAE is swelling, which can occur suddenly and without warning. Swelling typically affects the deeper layers of the skin and mucous membranes, leading to disfiguring, painful enlargements of body parts. Common areas for swelling include the face, hands, feet and gastrointestinal tract.
Facial Swelling: Facial swelling is a common manifestation of HAE, often affecting the lips, cheeks and eyes. It can be asymmetric and severe, leading to a disfigured appearance.
Abdominal Pain: Many HAE patients experience severe abdominal pain due to swelling in the intestinal wall. This pain can mimic a surgical abdomen, leading to unnecessary surgeries in some cases.
Difficulty Breathing: In some cases, HAE can lead to life-threatening airway swelling, causing difficulty breathing and potentially leading to asphyxiation. This is a medical emergency and requires immediate intervention.
Laryngeal Swelling: Swelling in the throat can also occur, leading to hoarseness, a sore throat and the sensation of a lump in the throat. In severe cases, it can obstruct the airway.
Extremity Swelling: Swelling can affect the hands and feet, making it difficult for individuals to perform daily activities.
Skin Swelling: HAE can also cause skin swelling without any apparent trigger. These episodes can be painful and disfiguring.
Nausea and Vomiting: Gastrointestinal swelling can lead to nausea, vomiting and diarrhea. It is often accompanied by severe abdominal pain.
Joint Pain: Joint pain and stiffness can occur during HAE attacks, often resembling symptoms of arthritis.
Understanding Hereditary Angioedema
Hereditary angioedema is a genetic disorder, typically caused by a deficiency or dysfunction of a protein called C1 inhibitor (C1-INH). C1-INH is essential for regulating several processes in the body, including controlling the production of bradykinin, a substance that causes blood vessels to dilate and leak fluid. In HAE patients, the lack of functional C1-INH results in uncontrolled bradykinin production, leading to swelling.
There are three types of hereditary angioedema:
Type I: Characterized by low levels of functional C1-INH. This is the most common type.
Type II: In this type, the levels of C1-INH are normal, but the protein does not function correctly.
Type III: A rare type of HAE that primarily affects women. It is not linked to C1-INH deficiency and is associated with mutations in another gene.
Causes of Hereditary Angioedema
HAE is primarily a genetic condition and it is inherited in an autosomal dominant manner. This means that a person with HAE has a 50% chance of passing the disorder to their offspring. However, HAE can occur in individuals with no family history of the condition due to spontaneous genetic mutations.
While HAE is primarily a genetic disorder, some triggers can lead to the onset of symptoms or exacerbate existing ones. These triggers can include injury or trauma, infection, hormonal fluctuations and stress.
Treatment Options for Hereditary Angioedema
The treatment of hereditary angioedema focuses on managing and preventing attacks. Here are some of the primary treatment options.
Acute Attack Treatment
This involves managing the symptoms during an acute attack. Options include:
- C1-INH replacement therapy: Administering C1-INH concentrate can help to control swelling during an attack.
- Icatibant: This medication can be injected to block the effects of bradykinin, reducing swelling and symptoms.
- Ecallantide: A medication that inhibits the activity of kallikrein, which plays a role in bradykinin production.
- Antihistamines and corticosteroids: These may be used to relieve itching and other allergic symptoms.
Preventing attacks is a key component of managing HAE. This can be achieved through:
- Prophylactic therapy: This involves regular administration of C1-INH concentrates or other medications to prevent attacks in individuals with frequent or severe episodes.
- Attenuated androgens: Medications like danazol and stanozolol can help reduce the frequency and severity of attacks but come with potential side effects.
- Takhzyro (Lanadelumab): Takhzyro is a monoclonal antibody that inhibits plasma kallikrein. It is administered subcutaneously every two or four weeks, depending on the patient, and has shown great promise in reducing HAE attack frequency and severity.
Hereditary angioedema is a rare but serious genetic disorder characterized by recurrent, painful swelling in various parts of the body. If you or someone you know has hereditary angioedema, it is crucial to work closely with a medical professional to develop a personalized treatment plan. With the right approach, individuals with HAE can manage their condition and improve their quality of life.
Learn more about what a weakened immune system looks like.